Cargando…
Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial
BACKGROUND: Patients suffering from fibrotic interstitial lung diseases (fILD) have a poor prognosis and a high symptom burden. Palliative treatment includes relief of symptoms such as breathlessness. There is no evidence-based treatment for chronic breathlessness but opioids are often used despite...
Autores principales: | Kronborg-White, Sissel, Andersen, Charlotte Uggerhøj, Kohberg, Charlotte, Hilberg, Ole, Bendstrup, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376842/ https://www.ncbi.nlm.nih.gov/pubmed/32703194 http://dx.doi.org/10.1186/s12931-020-01452-7 |
Ejemplares similares
-
Opioids: an unexplored option for treatment of dyspnea in IPF
por: Kohberg, Charlotte, et al.
Publicado: (2016) -
Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians
por: Bendstrup, Elisabeth, et al.
Publicado: (2019) -
NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease
por: Andersen, Charlotte, et al.
Publicado: (2016) -
Comorbidities in unclassifiable interstitial lung disease
por: Prior, Thomas Skovhus, et al.
Publicado: (2022) -
Emphysema mimicking interstitial lung disease: Two case reports
por: Juhl, Kasper S., et al.
Publicado: (2014)